10 employees
Venneos develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells
2014
$1.1M
from 2 investors over 2 rounds
Venneos GmbH raised $1.1M on September 11, 2015
Investors: Max Planck Society and High-Tech Gründerfonds